Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : AGNPF crawled time : 13:00 save search
Algernon Pharmaceuticals Announces Database Lock in Phase 2 Study of IPF and Chronic Cough
Published: 2022-06-13 (Crawled : 13:00) - biospace.com/
AGNPF | $0.0708 5.36% 178.69% 0
|
Health Technology
|
| O: 3.66%
H: 0.36%
C: 0.36%
phase 2
Algernon Pharmaceuticals Announces Lead Chronic Kidney Disease Drug Repirinast Reduced Fibrosis by 56% in a Preclinical NASH Study
Published: 2022-04-26 (Crawled : 13:00) - biospace.com/
AGNPF | $0.0708 5.36% 178.69% 0
|
Health Technology
|
| O: -8.89%
H: 0.0%
C: 0.0%
fibrosis drug disease preclinical kidney nash pre-clinical
Algernon Pharmaceuticals Discloses Novel Salt Patent Strategy as Part of its Psychedelic Drug DMT Intellectual Property
Published: 2022-01-24 (Crawled : 13:00) - biospace.com/
AGNPF | $0.0708 5.36% 178.69% 0
|
Health Technology
|
| O: -6.89%
H: 7.79%
C: 7.47%
als drug patent intel
Algernon Pharmaceuticals Announces Receipt of CAD$2M Cash Refund from Australian Research Program and Files Application to List its Common Shares on Nasdaq Capital Market
Published: 2021-10-21 (Crawled : 13:00) - biospace.com/
AGNPF | $0.0708 5.36% 178.69% 0
|
Health Technology
|
| O: -1.64%
H: 11.67%
C: 8.0%
application australia research
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
AGBA | News | $1.4 250.0% 35M
|
Finance
RWOD | $12.0 50.06% 3.9M
|
n/a
INDO | $4.9 20.1% 2.2M
|
Energy Minerals
NURO | $4.32 18.36% 66K
|
Health Technology
HUBC | $1.52 17.83% 4.7M
|
n/a
CARV 4 | $1.77 11.32% 8.5K
|
Finance
BROG | $1.23 10.81% 320K
|
Finance
PARA | $12.03 9.66% 5.8M
|
Information
ADAP | $0.98 9.08% 240K
|
Health Technology
POAI A | $1.25 8.69% 16K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.